Literature DB >> 24088615

Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis.

Priyanka Verma, Santwana Bhatnagar, Pradeep Kumar, Vinita Chattree, M M Parida, S L Hoti, Shakir Ali, D N Rao.   

Abstract

BACKGROUND: Many epidemic outbreaks of Chikungunya fever (CHIKF) have been reported throughout the world including India after its reemergence in 2005. The immuno protective role of envelope proteins during Chikungunya virus (CHIKV) infection has been reported. With the aim of identifying the immunodominant epitopes within the envelope protein we investigated the detailed analysis of fine specificity of antibody response in different individuals during CHIKV infection.
METHODS: The peptides corresponding to the full length of E1, E2 and E3 proteins of S27 strain of CHIKV were synthesized and their seroreactivity with CHIKV positive patients' sera collected from different epidemic regions of India was determined using indirect ELISA.
RESULTS: The data analysis reveals many potent epitopes throughout the length of envelope E2 protein thus displaying it as the most promising antigen for diagnostic purpose. We found that the main IgG isotype response to envelope protein was predominantly of subclass IgG3. Interestingly, most of the epitopes were found to be conserved for detecting IgM, IgG and IgG3 antibody response.
CONCLUSIONS: Peptides E2P3, E2P7, E2P16 and E2P17 were revealed as the most immunodominant peptides that together can form the basis for designing an accurate, economical and easy to synthesize a peptide-based immunodiagnostic for CHIKV. This study provides new and important insight into the humoral response generated by CHIKV S27 strain during the early phase of infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24088615     DOI: 10.1515/cclm-2013-0363

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  3 in total

1.  Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.

Authors:  Yiu-Wing Kam; Wendy W L Lee; Diane Simarmata; Roger Le Grand; Hugues Tolou; Andres Merits; Pierre Roques; Lisa F P Ng
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

2.  Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.

Authors:  Anna Andrew; Tholasi Nadhan Navien; Tzi Shien Yeoh; Marimuthu Citartan; Ernest Mangantig; Magdline S H Sum; Ewe Seng Ch'ng; Thean-Hock Tang
Journal:  PLoS Negl Trop Dis       Date:  2022-02-04

3.  Expression, Purification, and Refolding of Chikungunya Virus Full-Length Envelope E2 Protein along with B-Cell and T-Cell Epitope Analyses Using Immuno-Informatics Approaches.

Authors:  Manisha Shukla; Pankaj Chandley; Suman Tapryal; Narendra Kumar; Sulakshana P Mukherjee; Soma Rohatgi
Journal:  ACS Omega       Date:  2022-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.